Design Therapeutics Inc (DSGN)
5.46
+0.14
(+2.63%)
USD |
NASDAQ |
Nov 05, 11:48
Design Therapeutics Price to Book Value: 1.183 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.153 |
| November 01, 2024 | 1.127 |
| October 31, 2024 | 1.136 |
| October 30, 2024 | 1.207 |
| October 29, 2024 | 1.172 |
| October 28, 2024 | 1.198 |
| October 25, 2024 | 1.179 |
| October 24, 2024 | 1.160 |
| October 23, 2024 | 1.227 |
| October 22, 2024 | 1.229 |
| October 21, 2024 | 1.214 |
| October 18, 2024 | 1.213 |
| October 17, 2024 | 1.305 |
| October 16, 2024 | 1.225 |
| October 15, 2024 | 1.168 |
| October 14, 2024 | 1.116 |
| October 11, 2024 | 1.084 |
| October 10, 2024 | 1.012 |
| October 09, 2024 | 1.014 |
| October 08, 2024 | 1.066 |
| October 07, 2024 | 0.9872 |
| October 04, 2024 | 1.084 |
| October 03, 2024 | 1.023 |
| October 02, 2024 | 1.077 |
| October 01, 2024 | 1.116 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.166 |
| September 27, 2024 | 1.155 |
| September 26, 2024 | 1.175 |
| September 25, 2024 | 1.166 |
| September 24, 2024 | 1.172 |
| September 23, 2024 | 1.160 |
| September 20, 2024 | 1.274 |
| September 19, 2024 | 1.270 |
| September 18, 2024 | 1.222 |
| September 17, 2024 | 1.251 |
| September 16, 2024 | 1.203 |
| September 13, 2024 | 1.201 |
| September 12, 2024 | 1.266 |
| September 11, 2024 | 1.131 |
| September 10, 2024 | 1.222 |
| September 09, 2024 | 1.057 |
| September 06, 2024 | 1.012 |
| September 05, 2024 | 1.021 |
| September 04, 2024 | 1.042 |
| September 03, 2024 | 1.025 |
| August 30, 2024 | 1.030 |
| August 29, 2024 | 1.021 |
| August 28, 2024 | 1.021 |
| August 27, 2024 | 1.066 |
| August 26, 2024 | 1.162 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3867
Minimum
Aug 21 2023
4.034
Maximum
Mar 31 2021
1.693
Average
1.450
Median
Jan 26 2023
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.086 |
| Theriva Biologics Inc | 0.0780 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| Price | 5.46 |
| Earnings Yield | -16.48% |
| Market Cap | 309.15M |